The publications on this site are part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Informa
Skip to Page Content

Companies

Search All Companies »

Find a Company by Name

View All Companies

All
Industries

Biotechnology

Email Alert | RSS Feed

PTC Therapeutics Inc. / See Company Profile

Financing / Public offering nets $200mm for PTC Therapeutics / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 26, 2019

Alliance / PTC gets two rare disease therapies from Akcea / Strategic Transactions / Deal Date: Aug. 1, 2018 / Publish Date: Aug. 2, 2018

Acquisition / PTC adds gene therapy candidates through $945mm buy of Agilis / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 31, 2018

BridgeBio Pharma / See Company Profile

Financing / BridgeBio raises $299.2mm in late-stage round / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 24, 2019

Alliance / Leo Pharma partners with PellePharm in rare skin diseases; gains option to acquire / Strategic Transactions / Deal Date: Nov. 1, 2018 / Publish Date: Nov. 28, 2018

Financing / Eidos goes public netting $113.5mm / Strategic Transactions / Deal Date: Jun. 1, 2018 / Publish Date: Jun. 21, 2018

Melinta Therapeutics Inc. / See Company Profile

Alliance / Arrevus gets antibiotic from Melinta / Strategic Transactions / Deal Date: Feb. 1, 2019 / Publish Date: Feb. 6, 2019

Financing / Melinta secures up to $135mm in loan from Vatera / Strategic Transactions / Deal Date: Dec. 1, 2018 / Publish Date: Dec. 21, 2018

Alliance / Menarini gets rights to three Melinta antibiotics in 68 countries / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 2, 2018


Medical Devices

Email Alert | RSS Feed

Click Therapeutics Inc. / See Company Profile

Alliance / Otsuka pays up to $302mm for license to Click's CT152 for MDD / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 12, 2019

Financing / Digital therapeutics company Click brings in $17mm through Sanofi Ventures-led round / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 30, 2018

ConMed Corp. / See Company Profile

Financing / ConMed issues $345mm of its convertible senior notes / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 31, 2019

Alliance / ConMed acquires MedShape's ExoShape line / Strategic Transactions / Deal Date: Jul. 1, 2017 / Publish Date: Jul. 20, 2017

Acquisition / ConMed acquires SurgiQuest for $265mm / Strategic Transactions / Deal Date: Nov. 1, 2015 / Publish Date: Nov. 23, 2015

HighLife SAS / See Company Profile

Financing / HighLife brings in €32mm via Series B / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 18, 2019

Financing / HighLife raises €12.3mm in Series A financing / Strategic Transactions / Deal Date: Oct. 1, 2017 / Publish Date: Nov. 1, 2017

Alliance / Sorin Group makes €4.2mm equity investment in HighLife; gets option to buy company / Strategic Transactions / Deal Date: Nov. 1, 2012 / Publish Date: Dec. 13, 2012


In Vitro Diagnostics

Email Alert | RSS Feed

Mobidiag Ltd. / See Company Profile

Financing / Autobio makes €10m equity investment in Mobidiag as part of previously signed JV agreement / Strategic Transactions / Deal Date: Feb. 1, 2019 / Publish Date: Feb. 6, 2019

Alliance / Autobio, Mobidiag form JV in China / Strategic Transactions / Deal Date: Dec. 1, 2018 / Publish Date: Jan. 3, 2019

Financing / Mobidiag closes €4mm financing / Strategic Transactions / Deal Date: May 1, 2018 / Publish Date: May 30, 2018

Biocartis NV / See Company Profile

Financing / Biocartis closes oversubscribed €55.5mm PIPE / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 25, 2019

Alliance / Genomic Health develops Oncotype DX test for breast cancer on Biocartis' Idylla system; prostate cancer added / Strategic Transactions / Deal Date: Sep. 1, 2017 / Update Date: Dec. 1, 2018

Financing / Biocartis could get up to €24mm in debt financing / Strategic Transactions / Deal Date: Mar. 1, 2018 / Publish Date: Mar. 10, 2018

Quotient Ltd. / See Company Profile

Financing / Public offering nets $56.4mm for Quotient / Strategic Transactions / Deal Date: Dec. 1, 2018 / Publish Date: Dec. 11, 2018

Financing / Diagnostics company Quotient Ltd. raises $120mm through two closings of redeemable senior notes / Strategic Transactions / Deal Date: Oct. 1, 2016 / Update Date: Jul. 1, 2018

Financing / Quotient sells $39mm through private placement of shares and warrants / Strategic Transactions / Deal Date: Oct. 1, 2017 / Publish Date: Nov. 3, 2017


Pharmaceuticals

Email Alert | RSS Feed

Antengene Corp. / See Company Profile

Financing / Antengene raises $120mm in Series B round / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 4, 2019

Financing / Series A round brings $21mm to Antengene / Strategic Transactions / Deal Date: Aug. 1, 2017 / Publish Date: Jan. 4, 2019

Alliance / Celgene grants Antengene rights to TORC1/2 inhibitor for cancer / Strategic Transactions / Deal Date: Apr. 1, 2017 / Publish Date: Jan. 4, 2019

Aimmune Therapeutics Inc. / See Company Profile

Financing / Aimmune enters $170mm loan agreement; gets $40mm up front / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 11, 2019

Alliance / Aimmune gets $145mm equity investment from new partner Nestle Health Science; $98mm investment follows / Strategic Transactions / Deal Date: Nov. 1, 2016 / Update Date: Nov. 1, 2018

Financing / Public offering nets $190mm for Aimmune / Strategic Transactions / Deal Date: Feb. 1, 2018 / Publish Date: Feb. 24, 2018

Pear Therapeutics Inc. / See Company Profile

Financing / Pear Therapeutics closes $64mm Series C round / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 15, 2019

Alliance / Sandoz to commercialize Pear's reSET digital therapeutics to combat substance abuse / Strategic Transactions / Deal Date: Apr. 1, 2018 / Update Date: Dec. 1, 2018

Alliance / Novartis, Pear co-develop digital therapeutics for MS and schizophrenia / Strategic Transactions / Deal Date: Mar. 1, 2018 / Publish Date: Mar. 3, 2018

Biotechnology

Biotechnology

Email Alert | RSS Feed

PTC Therapeutics Inc. / See Company Profile

Financing / Public offering nets $200mm for PTC Therapeutics / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 26, 2019

Alliance / PTC gets two rare disease therapies from Akcea / Strategic Transactions / Deal Date: Aug. 1, 2018 / Publish Date: Aug. 2, 2018

Acquisition / PTC adds gene therapy candidates through $945mm buy of Agilis / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 31, 2018

BridgeBio Pharma / See Company Profile

Financing / BridgeBio raises $299.2mm in late-stage round / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 24, 2019

Alliance / Leo Pharma partners with PellePharm in rare skin diseases; gains option to acquire / Strategic Transactions / Deal Date: Nov. 1, 2018 / Publish Date: Nov. 28, 2018

Financing / Eidos goes public netting $113.5mm / Strategic Transactions / Deal Date: Jun. 1, 2018 / Publish Date: Jun. 21, 2018

Melinta Therapeutics Inc. / See Company Profile

Alliance / Arrevus gets antibiotic from Melinta / Strategic Transactions / Deal Date: Feb. 1, 2019 / Publish Date: Feb. 6, 2019

Financing / Melinta secures up to $135mm in loan from Vatera / Strategic Transactions / Deal Date: Dec. 1, 2018 / Publish Date: Dec. 21, 2018

Alliance / Menarini gets rights to three Melinta antibiotics in 68 countries / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 2, 2018

Medical
Devices

Medical Devices

Email Alert | RSS Feed

Click Therapeutics Inc. / See Company Profile

Alliance / Otsuka pays up to $302mm for license to Click's CT152 for MDD / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 12, 2019

Financing / Digital therapeutics company Click brings in $17mm through Sanofi Ventures-led round / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 30, 2018

ConMed Corp. / See Company Profile

Financing / ConMed issues $345mm of its convertible senior notes / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 31, 2019

Alliance / ConMed acquires MedShape's ExoShape line / Strategic Transactions / Deal Date: Jul. 1, 2017 / Publish Date: Jul. 20, 2017

Acquisition / ConMed acquires SurgiQuest for $265mm / Strategic Transactions / Deal Date: Nov. 1, 2015 / Publish Date: Nov. 23, 2015

HighLife SAS / See Company Profile

Financing / HighLife brings in €32mm via Series B / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 18, 2019

Financing / HighLife raises €12.3mm in Series A financing / Strategic Transactions / Deal Date: Oct. 1, 2017 / Publish Date: Nov. 1, 2017

Alliance / Sorin Group makes €4.2mm equity investment in HighLife; gets option to buy company / Strategic Transactions / Deal Date: Nov. 1, 2012 / Publish Date: Dec. 13, 2012

In Vitro
Diagnostics

In Vitro Diagnostics

Email Alert | RSS Feed

Mobidiag Ltd. / See Company Profile

Financing / Autobio makes €10m equity investment in Mobidiag as part of previously signed JV agreement / Strategic Transactions / Deal Date: Feb. 1, 2019 / Publish Date: Feb. 6, 2019

Alliance / Autobio, Mobidiag form JV in China / Strategic Transactions / Deal Date: Dec. 1, 2018 / Publish Date: Jan. 3, 2019

Financing / Mobidiag closes €4mm financing / Strategic Transactions / Deal Date: May 1, 2018 / Publish Date: May 30, 2018

Biocartis NV / See Company Profile

Financing / Biocartis closes oversubscribed €55.5mm PIPE / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 25, 2019

Alliance / Genomic Health develops Oncotype DX test for breast cancer on Biocartis' Idylla system; prostate cancer added / Strategic Transactions / Deal Date: Sep. 1, 2017 / Update Date: Dec. 1, 2018

Financing / Biocartis could get up to €24mm in debt financing / Strategic Transactions / Deal Date: Mar. 1, 2018 / Publish Date: Mar. 10, 2018

Quotient Ltd. / See Company Profile

Financing / Public offering nets $56.4mm for Quotient / Strategic Transactions / Deal Date: Dec. 1, 2018 / Publish Date: Dec. 11, 2018

Financing / Diagnostics company Quotient Ltd. raises $120mm through two closings of redeemable senior notes / Strategic Transactions / Deal Date: Oct. 1, 2016 / Update Date: Jul. 1, 2018

Financing / Quotient sells $39mm through private placement of shares and warrants / Strategic Transactions / Deal Date: Oct. 1, 2017 / Publish Date: Nov. 3, 2017

Pharmaceuticals

Pharmaceuticals

Email Alert | RSS Feed

Antengene Corp. / See Company Profile

Financing / Antengene raises $120mm in Series B round / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 4, 2019

Financing / Series A round brings $21mm to Antengene / Strategic Transactions / Deal Date: Aug. 1, 2017 / Publish Date: Jan. 4, 2019

Alliance / Celgene grants Antengene rights to TORC1/2 inhibitor for cancer / Strategic Transactions / Deal Date: Apr. 1, 2017 / Publish Date: Jan. 4, 2019

Aimmune Therapeutics Inc. / See Company Profile

Financing / Aimmune enters $170mm loan agreement; gets $40mm up front / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 11, 2019

Alliance / Aimmune gets $145mm equity investment from new partner Nestle Health Science; $98mm investment follows / Strategic Transactions / Deal Date: Nov. 1, 2016 / Update Date: Nov. 1, 2018

Financing / Public offering nets $190mm for Aimmune / Strategic Transactions / Deal Date: Feb. 1, 2018 / Publish Date: Feb. 24, 2018

Pear Therapeutics Inc. / See Company Profile

Financing / Pear Therapeutics closes $64mm Series C round / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 15, 2019

Alliance / Sandoz to commercialize Pear's reSET digital therapeutics to combat substance abuse / Strategic Transactions / Deal Date: Apr. 1, 2018 / Update Date: Dec. 1, 2018

Alliance / Novartis, Pear co-develop digital therapeutics for MS and schizophrenia / Strategic Transactions / Deal Date: Mar. 1, 2018 / Publish Date: Mar. 3, 2018

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel